These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28364821)

  • 1. Cholestatic Liver Diseases After Liver Transplant.
    Pena Polanco NA; Levy C; Martin EF
    Clin Liver Dis; 2017 May; 21(2):403-420. PubMed ID: 28364821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis.
    Martin EF; Levy C
    Semin Liver Dis; 2017 Nov; 37(4):305-313. PubMed ID: 29272893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Status of Liver Transplantation for Primary Biliary Cholangitis.
    Aguilar MT; Carey EJ
    Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
    Tanaka A; Kono H; Leung PSC; Gershwin ME
    Cell Immunol; 2020 Jan; 347():104021. PubMed ID: 31767117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation.
    Duclos-Vallée JC
    Acta Gastroenterol Belg; 2005; 68(3):331-6. PubMed ID: 16268420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy.
    Staufer K; Kivaranovic D; Rasoul-Rockenschaub S; Soliman T; Trauner M; Berlakovich G
    HPB (Oxford); 2018 Oct; 20(10):916-924. PubMed ID: 29937419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in PBC and PSC: indications and disease recurrence.
    Carbone M; Neuberger J
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):446-54. PubMed ID: 21459072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
    Visseren T; Darwish Murad S
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):187-198. PubMed ID: 28624107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of liver transplantation in autoimmune liver diseases.
    Zhong CP; Xi ZF; Xia Q
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBC-transplantation and disease recurrence.
    Nevens F
    Best Pract Res Clin Gastroenterol; 2018; 34-35():107-111. PubMed ID: 30343704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant immune-mediated cholangiopathies.
    Dumortier J; Conti F; Scoazec JY
    Curr Opin Gastroenterol; 2022 Mar; 38(2):98-103. PubMed ID: 35098931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome.
    Strasser S; Sheil AG; Gallagher ND; Waugh R; McCaughan GW
    J Gastroenterol Hepatol; 1993; 8(3):238-43. PubMed ID: 8518394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-liver transplant cholestatic disorder with biliary strictures: de novo versus recurrent primary sclerosing cholangitis.
    McPartland KJ; Lewis WD; Gordon FD; Pomfret EA; Pomposelli JJ; Jenkins R; Khettry U
    Pathol Int; 2009 May; 59(5):312-6. PubMed ID: 19432673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric liver transplantation for primary sclerosing cholangitis.
    Miloh T; Anand R; Yin W; Vos M; Kerkar N; Alonso E;
    Liver Transpl; 2011 Aug; 17(8):925-33. PubMed ID: 21506253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplantation for Cholestatic Liver Diseases in Adults.
    Khungar V; Goldberg DS
    Clin Liver Dis; 2016 Feb; 20(1):191-203. PubMed ID: 26593299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
    Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: recurrent autoimmune liver diseases after liver transplantation.
    Montano-Loza AJ; Bhanji RA; Wasilenko S; Mason AL
    Aliment Pharmacol Ther; 2017 Feb; 45(4):485-500. PubMed ID: 27957759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential benefit of mixed lymphocyte reaction assay-based immune monitoring after living donor liver transplantation for recipients with autoimmune hepatitis.
    Sakai H; Ishiyama K; Tanaka Y; Ide K; Ohira M; Tahara H; Abe T; Hirata F; Morimoto H; Hashimoto S; Tanimine N; Saeki Y; Shimizu S; Yano T; Kobayashi T; Tashiro H; Ohdan H
    Transplant Proc; 2014 Apr; 46(3):785-9. PubMed ID: 24767349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S99-108. PubMed ID: 11689782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.